EZH2 and myelodysplastic syndrome: This is in agreement with a previous study investigating EZH2 splicing abnormalities in MDS, which found a high degree of splicing deregulation between and within patients involving multiple exons [43], indicating that EZH2 splicing abnormalities play an important role alongside loss-of-function mutations in PRC2 dysregulation.